Pan American Health Organization/World Health Organization (PAHO/WHO), the Centers for Disease Control and Prevention (CDC), lan Task Force on Global Health (TFGH), kanthi kolaborasi karo Departemen Kesehatan (MoH), nindakake a latihan ing situs suwene seminggu kanggo nyiapake studi paparan ivermectin, diethylcarbamazine lan albendazole (IDA) (IIS) sing dijadwalake kanggo 2023. Survei kasebut dimaksudake kanggo ngonfirmasi yen filariasis limfatik (LF) infèksi wis suda menyang tingkat sing ora bisa dianggep minangka masalah kesehatan masyarakat ing Guyana lan bakal terus karo kegiatan penting liyane kanggo nduduhake pemberantasan penyakit ing negara kasebut.